Table 1 Clinico-pathological features of the patients included in the study
Parameter | qRT-PCR (n = 270) | IHC (n = 239) | ||
|---|---|---|---|---|
No. Pts | % | No. Pts | % | |
Age | ||||
≤ 55 | 15 | 5.6 | 12 | 5 |
56-65 | 81 | 30 | 72 | 30.1 |
66-75 | 138 | 51.1 | 122 | 51 |
> 75 | 36 | 13.3 | 33 | 13.8 |
Gleason-sp | ||||
2-6 | 109 | 40.4 | 87 | 36.4 |
7 | 129 | 47.8 | 123 | 51.5 |
Greater than 7 | 32 | 11.9 | 29 | 12.1 |
PSA (ng/ml) | ||||
10 or less | 155 | 57.6 | 133 | 55.9 |
10-20 | 74 | 27.5 | 69 | 29 |
Greater than 20 | 40 | 14.9 | 36 | 15.1 |
cT | ||||
cT2b or less | 248 | 92.2 | 219 | 92 |
cT3a or greater | 21 | 7.8 | 19 | 8 |
pT | ||||
pT2 or less | 135 | 50 | 115 | 48.1 |
pT3 or greater | 135 | 50 | 124 | 51.9 |
pNa | ||||
pN0 | 236 | 95.2 | 209 | 95.4 |
pN1 or greater | 12 | 4.8 | 10 | 4.6 |
Margins | ||||
Negative | 137 | 50.7 | 116 | 48.5 |
Positive | 133 | 49.3 | 123 | 51.5 |
TMPRSS2/ERGb,c | ||||
Negative | 92 | 34.1 | 105 | 48.8 |
Positive | 178 | 65.9 | 110 | 51.2 |